178 related articles for article (PubMed ID: 3904422)
1. The case for parathyroid hormone.
Mayor GH
Am J Kidney Dis; 1985 Nov; 6(5):306-8. PubMed ID: 3904422
[No Abstract] [Full Text] [Related]
2. The case against aluminum affecting parathyroid function.
Alfrey AC
Am J Kidney Dis; 1985 Nov; 6(5):309-12. PubMed ID: 4061453
[TBL] [Abstract][Full Text] [Related]
3. Clinical and laboratory features of aluminum-related bone disease: differences between sporadic and "epidemic" forms of the syndrome.
Norris KC; Crooks PW; Nebeker HG; Hercz G; Milliner DS; Gerszi K; Slatopolsky E; Andress DL; Sherrard DJ; Coburn JW
Am J Kidney Dis; 1985 Nov; 6(5):342-7. PubMed ID: 4061454
[No Abstract] [Full Text] [Related]
4. Aluminum - related osteomalacia.
Ott SM
Int J Artif Organs; 1983 Jul; 6(4):173-5. PubMed ID: 6629522
[No Abstract] [Full Text] [Related]
5. [New ideas concerning the role of the parathyroid hormone and vitamin D in disorders of phosphocalcic metabolism].
Corvilain J; Brauman H; Manderlier T; Fuss M
Brux Med; 1975 Jan; 55(1):7-16. PubMed ID: 1116034
[No Abstract] [Full Text] [Related]
6. Osteomalacia and bone disease arising from aluminum.
Coburn JW; Norris KC; Nebeker HG
Semin Nephrol; 1986 Mar; 6(1):68-89. PubMed ID: 3110896
[No Abstract] [Full Text] [Related]
7. Aluminum, parathyroid hormone, and osteomalacia.
Burnatowska-Hledin MA; Kaiser L; Mayor GH
Spec Top Endocrinol Metab; 1983; 5():201-26. PubMed ID: 6422572
[TBL] [Abstract][Full Text] [Related]
8. The role of aluminium in experimental osteomalacia. Preliminary results: Aluminium content and bone mineralization.
Costantini S; Bonucci E; Mocetti P; Ballanti P; Giordano R; Vernillo I; Ioppolo A; Mantovani A; Stasolla D
Ann Ist Super Sanita; 1986; 22(2):689-95. PubMed ID: 3752831
[No Abstract] [Full Text] [Related]
9. Renal osteodystrophy--pathogenesis and treatment.
Cushner HM; Adams ND
Am J Med Sci; 1985 Dec; 290(6):234-45. PubMed ID: 3909812
[TBL] [Abstract][Full Text] [Related]
10. The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone disease. Part III of IV parts; PTH and osteoblasts, the relationship between bone turnover and bone loss, and the state of the bones in primary hyperparathyroidism.
Parfitt AM
Metabolism; 1976 Sep; 25(9):1033-69. PubMed ID: 785157
[No Abstract] [Full Text] [Related]
11. Review: Renal osteodystrophy--pathogenesis and treatment.
Cushner HM; Adams ND
Am J Med Sci; 1986 Apr; 291(4):264-75. PubMed ID: 3518448
[TBL] [Abstract][Full Text] [Related]
12. [Problems in mineral and bone metabolism in chronic renal insufficiency].
Garcia-Pascual B; Courvoisier B
Probl Actuels Endocrinol Nutr; 1977; (20):175-86. PubMed ID: 896682
[No Abstract] [Full Text] [Related]
13. Aluminum absorption and distribution: effect of parathyroid hormone.
Mayor GH; Keiser JA; Makdani D; Ku PK
Science; 1977 Sep; 197(4309):1187-9. PubMed ID: 897661
[TBL] [Abstract][Full Text] [Related]
14. Aluminum osteopathy.
Cournot-Witmer G
Contrib Nephrol; 1984; 38():59-64. PubMed ID: 6713901
[No Abstract] [Full Text] [Related]
15. Renal osteodystrophy.
Kanis JA; Cundy TF; Hamdy NA
Baillieres Clin Endocrinol Metab; 1988 Feb; 2(1):193-241. PubMed ID: 3044329
[TBL] [Abstract][Full Text] [Related]
16. Do serum aluminum levels reflect underlying skeletal aluminum accumulation and bone histology before or after chelation by deferoxamine?
Hodsman AB; Hood SA; Brown P; Cordy PE
J Lab Clin Med; 1985 Dec; 106(6):674-81. PubMed ID: 4067379
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal absorption of aluminum.
Ihle BU; Becker GJ
Am J Kidney Dis; 1985 Nov; 6(5):302-5. PubMed ID: 3904421
[No Abstract] [Full Text] [Related]
18. Hormonal control of skeletal and mineral homeostasis.
Rasmussen H; Bordier P; Kurokawa K; Nagata N; Ogata E
Am J Med; 1974 Jun; 56(6):751-8. PubMed ID: 4364694
[No Abstract] [Full Text] [Related]
19. Aluminum-related osteomalacia in renal-failure patients.
Vick KE; Johnson CA
Clin Pharm; 1985; 4(4):434-9. PubMed ID: 3899471
[TBL] [Abstract][Full Text] [Related]
20. Bone disease and aluminum: pathogenic considerations.
Goodman WG
Am J Kidney Dis; 1985 Nov; 6(5):330-5. PubMed ID: 3904425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
